Journal
Oncogene
Publication Date
2018
Volume
37
Inclusive Pages
4581-4598
Document Type
Open Access Publication
DOI
10.1038/s41388-018-0284-2
Rights and Permissions
Gates LA, Gu G, Chen Y, et al (2018) Proteomic profiling identifies key coactivators utilized by mutant ERα proteins as potential new therapeutic targets. Oncogene, 37:4581-4598. DOI: 10.1038/s41388-018-0284-2 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Recommended Citation
Li, Shunqiang; Shao, Jieya; and et al, "Proteomic profiling identifies key coactivators utilized by mutant ERα proteins as potential new therapeutic targets." Oncogene. 37, 4581-4598. (2018).
https://digitalcommons.wustl.edu/open_access_pubs/7736
Supplementary Information clean
41388_2018_284_MOESM2_ESM.xlsx (283 kB)
Supplementary Table 7 for Fig 1 and Supp Fig 1
41388_2018_284_MOESM3_ESM.xlsx (329 kB)
Supplementary Table 7 for Supp Fig 2
41388_2018_284_MOESM4_ESM.xlsx (322 kB)
Supplementary Table 7 for Fig 6
